Zacks Research Issues Optimistic Outlook for Itron Earnings

Itron, Inc. (NASDAQ:ITRI) – Equities researchers at Zacks Research upped their Q4 2024 earnings estimates for Itron in a report released on Tuesday, November 19th. Zacks Research analyst R. Department now expects that the scientific and technical instruments company will earn $1.02 per share for the quarter, up from their previous forecast of $0.92. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q3 2025 earnings at $1.19 EPS, Q2 2026 earnings at $1.32 EPS, Q3 2026 earnings at $1.38 EPS and FY2026 earnings at $5.29 EPS.

Itron (NASDAQ:ITRI) last issued its earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.71. The company had revenue of $615.46 million during the quarter, compared to analysts’ expectations of $596.41 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. Itron’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.98 EPS.

Other equities analysts have also recently issued research reports about the stock. BNP Paribas began coverage on shares of Itron in a research report on Thursday, September 5th. They issued an “outperform” rating and a $133.00 price objective on the stock. Roth Mkm upped their price target on Itron from $125.00 to $130.00 and gave the company a “buy” rating in a research report on Friday, November 1st. Stephens reiterated an “equal weight” rating and issued a $110.00 price objective on shares of Itron in a research report on Monday, August 5th. Robert W. Baird boosted their target price on Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. Finally, Janney Montgomery Scott started coverage on shares of Itron in a report on Friday, September 27th. They issued a “buy” rating and a $131.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $123.92.

Itron Stock Down 0.8 %

Shares of Itron stock opened at $114.11 on Thursday. The company’s 50 day moving average price is $108.87 and its 200-day moving average price is $104.86. Itron has a 52-week low of $64.96 and a 52-week high of $124.90. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.83 and a current ratio of 3.36. The stock has a market capitalization of $5.15 billion, a price-to-earnings ratio of 23.38, a P/E/G ratio of 0.86 and a beta of 1.46.

Insider Buying and Selling

In other Itron news, CEO Thomas Deitrich sold 887 shares of Itron stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $102.15, for a total value of $90,607.05. Following the completion of the transaction, the chief executive officer now directly owns 205,276 shares of the company’s stock, valued at approximately $20,968,943.40. The trade was a 0.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Joan S. Hooper sold 509 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $102.15, for a total transaction of $51,994.35. Following the sale, the chief financial officer now directly owns 72,338 shares of the company’s stock, valued at $7,389,326.70. This trade represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,066 shares of company stock worth $4,092,737 in the last 90 days. Insiders own 1.45% of the company’s stock.

Institutional Investors Weigh In On Itron

Several institutional investors have recently modified their holdings of the business. Virtue Capital Management LLC raised its position in Itron by 2.2% in the 3rd quarter. Virtue Capital Management LLC now owns 7,830 shares of the scientific and technical instruments company’s stock worth $836,000 after buying an additional 168 shares during the last quarter. Coldstream Capital Management Inc. bought a new stake in shares of Itron in the third quarter worth approximately $350,000. Geode Capital Management LLC raised its holdings in shares of Itron by 0.5% during the third quarter. Geode Capital Management LLC now owns 1,074,940 shares of the scientific and technical instruments company’s stock valued at $114,835,000 after purchasing an additional 5,630 shares during the last quarter. Continuum Advisory LLC lifted its position in Itron by 42.1% during the third quarter. Continuum Advisory LLC now owns 344 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 102 shares during the period. Finally, Y Intercept Hong Kong Ltd boosted its holdings in Itron by 8.6% in the third quarter. Y Intercept Hong Kong Ltd now owns 7,912 shares of the scientific and technical instruments company’s stock worth $845,000 after purchasing an additional 624 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.